February 11th 2021 Drug delivery with bioadhesive nanoparticles shows exceptional promise. One in five people in the U.S. will develop skin cancer in their lifetime, with the most common type of malignant skin cancer, squamous cell carcinoma or SCC, killing 10,000 people each year1,2. Cases of skin cancer are steadily rising, and in fact, skin … Continue reading Research with mice paves the way for injectable skin cancer treatment
Back in March I discussed a new therapy that combines nanotechnology and RNA interference (RNAi) to treat metastatic melanoma, and how basic and applied animal research has contributed to its’ development. Now researchers at the Georgia Institute of Technology and Emory University have reported the development of another nanotechnology and RNAi approach to treating inflammatory … Continue reading Mice, Nanotechnology, and Inflammatory Bowel Disease
The publication of the preliminary results of a small clinical trial of a new therapy called RNA interference (RNAi) online in the scientific journal Nature is causing quite a stir in the scientific community this week. A team led by Professor Mark E. Davis at Caltech targeted the delivery of a nanoparticle only 70 nanometers … Continue reading RNAi: Send in the Nanobots!